 | ||
|
| Home Annual/Quarterly Updates About Us
|
Boston Scientific Corporation Conclusion: According to the Company’s FORM 10-Q for the quarterly period ended September 30, 2001, in August 1999, lead plaintiffs and lead counsel filed a purported consolidated class action complaint adding allegations that the Company issued false and misleading statements with respect to the launch of its NIR ON(R) Ranger(TM) with Sox(TM) coronary stent delivery system and the system's subsequent recall. Following a hearing on a motion by the Company and its officers, the court dismissed the case without prejudice on August 16, 2001.
The original Complaint alleges that defendants issued false and misleading statements during the Class Period about its previously reported revenues and assets. Specifically, the complaint alleges that the Company improperly recorded $40-50 million in revenues in the first nine months of fiscal 1998 due to accounting irregularities at its Japanese subsidiary. In addition, the Complaint alleges that there is an additional $40 million of net unrealizable assets on Boston Scientific's balance sheet also due to similarly improper sales recorded in prior periods. Plaintiff alleges that defendants' misleading positive statements about the Company's financial results artificially inflated the price of Boston Scientific common stock. When news of Boston Scientific's improper accounting practices was reported on November 3, 1998, the Company's stock fell $5.875 per share or 11% before trading in the stock was halted. When trading resumed on November 4, 1998, the stock opened at $40-1/4, down another $6-1/8. The total percentage drop was 23%.
INDUSTRY CLASSIFICATION:
SIC Code: 3841
Sector: Healthcare
Industry: Medical Equipment & Supplies
| COMPANY/ISSUER NAME: | Boston Scientific Corporation |
| COMPANY/ISSUER TICKER: | BSX |
| COMPANY WEBSITE: | http://www.bsci.com |
| FIRST IDENTIFIED COMPLAINT IN THE DATABASE | |||||||||||||||||
| Michael Moore, et al. v. Boston Scientific Corporation, et al. | |||||||||||||||||
| |||||||||||||||||
| DOCUMENTS FOR THE FIRST IDENTIFIED COMPLAINT | |||
| Class Action Complaint for Violations of Federal Securities Laws | |||
| Type: Complaint | Date on the document: 11/04/1998 | ||
| Docket | |||
| Type: Docket | Date on the document: 09/12/2000 | ||
| REFERENCE COMPLAINT | |||||||||||||||||
| In Re: Boston Scientific Corporation Securities Litigation | |||||||||||||||||
| |||||||||||||||||
| DOCUMENTS FOR THE REFERENCE COMPLAINT | |||
| U.S. District Court Civil Docket | |||
| Type: Docket | Date on the document: 02/20/2002 | ||
| OTHER DOCUMENTS | |||
| Case Name and/or Number: | |||
| Type: | Date on the document: | ||
WARNING AND DISCLAIMER OF LIABILITY:
The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful.
Go to Search page | Go to Case Index page | Back to Top